0001950047-23-005327.txt : 20231122 0001950047-23-005327.hdr.sgml : 20231122 20231122161708 ACCESSION NUMBER: 0001950047-23-005327 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc. CENTRAL INDEX KEY: 0001798749 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831377888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40544 FILM NUMBER: 231433708 BUSINESS ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-443-2400 MAIL ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: NIVEN RALPH CENTRAL INDEX KEY: 0001168060 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AEROVATE THERAPEUTICS, INC. STREET 2: 200 BERKELEY STREET, FLOOR 18 CITY: BOSTON STATE: MA ZIP: 02116 144 1 primary_doc.xml 144 0001168060 XXXXXXXX LIVE 0001798749 AEROVATE THERAPEUTICS, INC. 001-40544 930 Winter Street, Suite M-500 Waltham MA 02451 (617) 443-2400 RALPH W NIVEN Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

13800 207000.00 27668887 11/22/2023 NASDAQ COMMON 11/22/2023 Stock Option Exercise ISSUER N 13800 11/22/2023 Cash Y 11/22/2023 05/25/2023 /s/ Ralph Niven